Curavit Clinical Research

Curavit Clinical Research is an 'Innovation CRO' founded in 2019 that operates at the intersection of digital health and clinical research services. Its core offering is a Virtual Clinical Site (VCS) platform that enables fully decentralized trials, complemented by a full-service CRO capability. The company primarily serves sponsors of digital therapeutics (DTx) and other innovative therapies, helping them generate real-world evidence and navigate regulatory pathways. Curavit's model addresses chronic challenges in clinical research, such as patient recruitment and geographic accessibility, by conducting trials remotely.

A flexible Virtual Clinical Site (VCS) platform that integrates best-in-class tools for remote patient recruitment, eConsent, telehealth visits, remote monitoring via wearables/apps, direct-to-patient supply chain, and integrated data capture to enable fully decentralized and hybrid clinical trials.

Curavit competes with large, full-service CROs (e.g., IQVIA, ICON, PPD) that are adding decentralized capabilities, as well as a growing number of niche DCT technology providers and boutique CROs. Its key differentiator is being a pure-play 'Innovation CRO' built specifically for virtual trials, offering deep expertise in digital health and a flexible, integrated platform model.